Respiratory medicine

British Journal of General Practice

Volumn 54, Issue 504, 2004, Pages 539-545

  Pinnock, Hilary ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Whitstable Health Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; FORMOTEROL; IMMUNOGLOBULIN E ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONOCLONAL ANTIBODY; OMALIZUMAB; OXYGEN; PHOSPHODIESTERASE IV INHIBITOR; STEROID; THEOPHYLLINE; THEOPHYLLINE DERIVATIVE; TIOTROPIUM BROMIDE;

ADD ON THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BREATHING EXERCISE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FORCED EXPIRATORY FLOW; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HOME CARE; HUMAN; INHALATION SPACER; METERED DOSE INHALER; MOUTH LESION; OXYGEN THERAPY; PALLIATIVE THERAPY; PATIENT MONITORING; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; SELF MEDICATION; SKIN BRUISING; SPIROMETRY; STEROID THERAPY;

ASTHMA; FAMILY PRACTICE; HOME CARE SERVICES, HOSPITAL-BASED; HUMANS; PULMONARY DISEASE (SPECIALTY); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYSTEM AGENTS; SELF CARE;

EID: 3142669914     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. NHS Confederation, British Medical Association. New GMS contract 2003: investing in general practice. London: BMA, 2003.
2. The British Thoracic Society, Scottish Intercollegiate Guideline Network. British guideline on the management of asthma. Thorax 2003; 58(suppl 1): i1-i94.
3. National Institute for Clinical Excellence. National clinical guideline on the management of chronic obstructive pulmonary disease in adults in primary and secondary care. National Collaborating Centre for Chronic Conditions. Thorax 2004; 59(suppl 1): 1-232.
4. Martinez FD. Development of wheezing disorders and asthma in pre-school children. Paediatrics 2002; 109: 362-367.
5. Stephenson P. Management of wheeze and cough in infants and pre-school children in primary care. Prim Care Respir J 2002; 11(2): 42-44.
6. Cochran D. Diagnosing and treating chesty infants. BMJ 1998; 316: 1546-1547.
7. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well being of patients with chronic conditions: results from the medical outcomes study. JAMA 1989; 262: 907-913.
8. Pauwels RA, Buist AS, Calverley P. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. GOLD Workshop summary: updated 2003. http://www.goldcopd.com/workshop/toc.html (accessed 7 Jun 2004).
9. Burge PS, Calverley PMA, Jones PW, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE study. BMJ 2000; 320: 1297-1303.
10. 1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
11. Badgett RG, Tanaka DJ. Is screening for chronic obstructive pulmonary disease justified? Preventive Med 1997; 26: 466-472.
12. Calverley PMA. COPD: early detection and intervention. Chest 2000; 117(suppl 2): 365S-371S.
13. van Schayck CP, Loozen JMC, Wagena E, et al. Detecting patients at high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 2002; 324: 1370-1373.
14. Stratelis G, Jakobsson J, Molstad S, Zetterstrom O. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract 2004; 54: 201-206.
15. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software, 2003.
16. Global Initiative for Asthma. Global strategy for asthma management and prevention. GINA workshop report: updated November 2003. http://ginasthma.com/wr.html (accessed 7 Jun 2004).
17. Pearson MG, Bucknall CE, (eds). Measuring clinical outcome in asthma: a patient focused approach. London: Royal College of Physicians, 1999.
18. Jones K, Clearly R, Hyland M. Predictive value of a simple asthma morbidity index in a general practice. Br J Gen Pract 1999; 49: 23-26.
19. Jones RCM, Freegard S, Reeves M, et al. The role of the practice nurse in the management of asthma. Prim Care Respir J 2001; 10: 109-111.
20. National Health Service, England and Wales. The National Health Service (General Medical Services) Regulations 1992. London: HMSO, 1992.
21. Price D, Wolfe S. Delivery of asthma care: patients' use of and views on healthcare services, as determined from a nationwide interview survey. Asthma J 2000; 5: 141-144.
22. Gruffydd-Jones K, Nicholson I, Best L, et al. Why don't patients attend the asthma clinic? Asthma Gen Pract 1999; 7: 36-38.
23. Pinnock H, Bawden R, Proctor S, et al. Accessibility, acceptability and effectiveness of telephone reviews for asthma in primary care: randomised controlled trial. BMJ 2003; 326: 477-479.
24. Price D, van der Molen T. The Aberdeen primary care COPD research needs statement. Prim Care Respir J 2001; 10: 47-49.
25. Chavannes N, Vollenberg JJH, van Schayck CP, et al. Effects of physical activity in mild to moderate COPD: a systematic review. Br J Gen Pract 2002; 52: 574-578.
26. Fletcher CM, Elmes PC, Fairbairn MB et al. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ 1959; 2: 257-266.
27. Roberts CM, Bulger JR, Melchor R, et al. Value of pulse oximetry in screening for long term oxygen therapy requirement. Eur Respir J 1993; 6: 559-562.
28. Bousquet J, van Cauwenberge R Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108(suppl): s147-s333.
29. British Society for Allergy and Clinical Immunology. Rhinitis management guidelines. 3rd edn. London: Dunitz, 2000.
30. Sheikh A, Hurwitz B. House dust mite avoidance measures for perennial allergic rhinitis (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
31. Gøtzsche PC, Johansen HK, Burr ML, et al. House dust mite control measures for asthma (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
32. Woodcock A, Forster L, Matthews E, et al. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N Engl J Med 2003; 349: 225-236.
33. Walters EH, Walters JAE, Gibson, MDP. Inhaled long-acting beta agonists for stable chronic asthma (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
34. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405-1411.
35. Shrewsbury S, Pyke S, Britton M. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ 2000; 320: 1368-1373.
36. Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratidine as treatment for seasonal allergic rhinitis: a randomised, placebo controlled clinical trial. J Allergy Clin Immunol 2000; 105: 917-922.
37. Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene recepter antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001; 108: E48.
38. Ducharme FM. Anti-leukotrienes as add-on therapy to inhaled glucocorticosteroids inpatients with asthma: systematic review of current literature. BMJ 2002; 324: 1545-1548.
39. Anonymous. Managing stable chronic obstructive pulmonary disease. Drug Ther Bull 2001; 39(11): 81-84.
40. Anonymous. Tiotropium for chronic obstructive pulmonary disease. Drug Ther Bull 2003; 41(2): 15-16.
41. Vestbo J, Sorensen T, Lange P et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999; 353: 1819-1823.
42. Pauwels RA, Lofdahl CG, Laitenen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 1999; 340: 1948-1953.
43. Lung Health Study Research Group. Effect on inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 1819-1823.
44. Jones RCM, Copper S, Riley O, et al. A pilot study of pulmonary rehabilitation in primary care. Br J Gen Pract 2002; 52: 567-568.
45. Lacasse Y, Wong E, Guyatt GH, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348: 1115-1119.
46. Cambach W, Wagenaar RC, Koelman TW, et al. The long-term effects of pulmonary rehabilitation in patients with asthma and chronic obstructive pulmonary disease: a research synthesis. Arch Phys Med Rehabil 1999; 80: 103-111.
47. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of chronic obstructive lung disease. The SUPPORT investigators. Am J Respir Crit Care Med 1996; 154: 959-967.
48. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000; 55: 1000-1006.
49. Jennings A-L, Davies AN, Higgins JPT, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002; 57: 939-944.
50. Abrahm JL, Hansen-Flaschen J. Hospice care for patients with advanced lung disease. Chest 2002; 121: 220-229.
51. Jones K, Cassidy P, Killen J, et al. The feasibility and usefulness of oximetry measurements in primary care. Prim Care Respir J 2003; 12: 4-6.
52. Buhl R. Omalizumab (Xolair) improves quality of life in adult patients with allergic asthma: a review. Respir Med 2003; 97: 123-129.
53. Thoonen BRA, Jones KR van Rooij HA, et al. Self-treatment of asthma: possibilities and perspectives from the practitioner's point of view. Fam Pract 1999; 16: 117-122.
54. Charlton I, Charlton G, Broomfield J, Mullee MA. Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice. BMJ 1990; 301: 1355-1359.
55. Foresi A, Morelli MC, Catena E. Low dose budesonide with the addition of an increased dose during exacerbations is effective in long term asthma control. Chest 2000; 117: 440-446.
56. Toelle BG, Ram FSF Written individualised management plans for asthma in children and adults (Cochrane Review). The Cochrane Library, Issue 3. Oxford: Update Software, 2003.
57. Douglas J, Aroni R, Goeman D, et al. A qualitative study of action plans for asthma. BMJ 2002; 324: 1003-1005.
58. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilisation in patients with chronic obstructive pulmonary disease. Arch Intern Med 2003; 163: 585-591.
59. Watson PB, Town GI, Holbrook N, et al. Evaluation of a self-management plan for chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 1267-1271.
60. The Respiratory Alliance. Bridging the gap. Leeds: General Practice Airways Group, 2003.
61. Jones RCM, Freegard S, Reeves M, et al. The role of the practice nurse in the management of chronic obstructive pulmonary disease. Prim Care Respir J 2001; 10: 106-108.
62. Eaton T, Withey S, Garrett J, et al. Spirometry in primary care practice. The importance of quality assurance and the impact of spirometry workshops. Chest 1999; 116: 416-423.
63. British Thoracic Society. The burden of lung disease. London: British Thoracic Society, 2001.
64. Damiani M, Dixon J. Managing the pressure. Emergency hospital admissions in London 1997-2001. London: The Kings Fund, 2002.
65. Davies L, Wilkinson M, Bonner S, et al. 'Hospital at home' versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial. BMJ 2000; 321: 1265-1268.
66. Cotton MM, Bucknall CE, Dagg KD, et al. Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 2000; 55: 902-906.
67. Ojoo JC, Moon T, McGlone S, et al. Patients' and carers' preferences in two models of care for acute exacerbations of COPD: results of a randomised controlled trial. Thorax 2002; 57: 167-169.
68. Royal College of Physicians. Containing the allergy epidemic. London: Royal College of Physicians, 2003.